Key terms
About BIOL
BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1984 and is headquartered in Lake Forest, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest BIOL news
Mar 23
7:35am ET
Biolase’s Strong Q4 Performance and Positive 2024 Outlook Affirm Buy Rating
Mar 22
7:05am ET
Biolase price target lowered to 40c from $2.50 at Benchmark
Feb 22
4:05pm ET
Maxim Group Reaffirms Their Buy Rating on Biolase (BIOL)
Feb 21
7:12am ET
Biolase Announces Common Stock Shares Update
Feb 15
5:35pm ET
Biolase Raises $7 Million, Expands Capital and Ensures Compliance
Jan 19
6:11am ET
Biolase files to sell units, no amount given
Dec 26
5:25pm ET
Biolase files to sell 2.22M shares of common stock for holders
No recent press releases are available for BIOL
BIOL Financials
Key terms
Ad Feedback
BIOL Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
BIOL Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range